Kiryluk Lab

Inclusion Criteria

This study will be accepting all ages diagnosed with MCD, FSGS, MN or IgAN on a first diagnostic kidney biopsy.

• Diagnosis of MCD, FSGS, MN, or IgAN on first diagnostic kidney biopsy, as per specified pathology definitions
• First diagnostic kidney biopsy within 5 years of study enrollment
• Access to first kidney biopsy report and/or slides
• All ages
• Willingness to comply with study requirements, including intention to fully participate in protocol-specified follow-up at a clinical study site
• Informed consent and, where age appropriate, informed assent

Exclusion Criteria

• ESKD, defined as chronic dialysis or kidney transplant
• Institutionalized patient
• Solid organ or bone marrow transplant recipient at time of first kidney biopsy
• Diagnosis of any of the following at the time of first diagnostic kidney biopsy:
• Diabetes mellitus
• Systemic lupus erythematosus
• HIV infection
• Active malignancy, except for non-melanoma skin cancer
• Active Hepatitis B or C infection, defined as positive viral load

More detailed eligibility criteria will be verified by our CureGN team.